LCM
TXG icon

Landscape Capital Management’s 10x Genomics TXG Stock Holding History

Landscape Capital Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$613K Sell
15,998
-91,218
-85% -$2.39M 0.04% 464
2026
Q1 		$2.28M Buy
107,216
+55,717
+108% +$1.11M 0.14% 221
2025
Q4 		$840K Sell
51,499
-19,570
-28% -$296K 0.06% 390
2025
Q3 		$831K Buy
+71,069
New +$927K 0.05% 393
2019
Q4 		– Sell
-17,676
Closed -$891K – 830
2019
Q3 		$891K Buy
+17,676
New +$978K 0.07% 295

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Landscape Capital Management's TXG Position: Q2 2026 in Review

Landscape Capital Management reduced its 10x Genomics (TXG) stake by 85% in Q2 2026, selling an estimated $2.39M and leaving 15,998 shares worth $613K. The position accounts for 0.04% of the portfolio, ranked #464.

Landscape Capital Management first reported a position in TXG in Q3 2019 and has held it in 5 quarters since. The position peaked at $2.28M in Q1 2026. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Landscape Capital Management held 15,998 shares of 10x Genomics worth $613K as of Q2 2026.
  • Landscape Capital Management sold 91,218 10x Genomics shares in Q2 2026, an estimated $2.39M.
  • 10x Genomics made up 0.04% of Landscape Capital Management's portfolio in Q2 2026, its #464 holding.
  • Landscape Capital Management first reported a position in 10x Genomics in Q3 2019 and has held it in 5 quarters since.
  • Landscape Capital Management's 10x Genomics position peaked at $2.28M in Q1 2026.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.